Although we observed a higher weight loss than considering all GLP1-RA treatments (−4.69% versus −3.93%) (Supplementary Fig. 6), we confirmed the lack of effect of BMI and T2D PGS on weight loss observed in primary analyses (Supplementary Table 14 and Supplementary Fig. 7). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.